Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$841000.0.

  • Journey Medical's Other Working Capital Changes rose 2774.91% to -$841000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $396000.0, marking a year-over-year increase of 2452.83%. This contributed to the annual value of -$376000.0 for FY2024, which is 23476.7% down from last year.
  • Journey Medical's Other Working Capital Changes amounted to -$841000.0 in Q3 2025, which was up 2774.91% from $84000.0 recorded in Q2 2025.
  • Journey Medical's Other Working Capital Changes' 5-year high stood at $2.7 million during Q4 2023, with a 5-year trough of -$1.2 million in Q3 2024.
  • Over the past 5 years, Journey Medical's median Other Working Capital Changes value was -$478000.0 (recorded in 2021), while the average stood at -$1368.4.
  • In the last 5 years, Journey Medical's Other Working Capital Changes soared by 753548.39% in 2022 and then plummeted by 83763.44% in 2023.
  • Over the past 5 years, Journey Medical's Other Working Capital Changes (Quarter) stood at $31000.0 in 2021, then soared by 7535.48% to $2.4 million in 2022, then grew by 12.55% to $2.7 million in 2023, then dropped by 26.05% to $2.0 million in 2024, then tumbled by 142.69% to -$841000.0 in 2025.
  • Its last three reported values are -$841000.0 in Q3 2025, $84000.0 for Q2 2025, and -$817000.0 during Q1 2025.